Olema Pharmaceuticals, Inc. - OLMA

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 20, 2026 SCHEDULE 13G Invus Public Equities, L.P. 4.5% 3,898,500 View
Mar 20, 2026 SCHEDULE 13G Invus Public Equities Advisors, LLC 4.5% 3,898,500 View
Mar 20, 2026 SCHEDULE 13G Invus Global Management, LLC 4.5% 3,898,500 View
Mar 20, 2026 SCHEDULE 13G Siren, L.L.C. 4.5% 3,898,500 View
Mar 20, 2026 SCHEDULE 13G Avicenna Life Sci Master Fund LP 0.6% 563,449 View
Mar 20, 2026 SCHEDULE 13G Avicenna Life Sci Master GP LLC 0.6% 563,449 View
Mar 20, 2026 SCHEDULE 13G Ulys, L.L.C. 0.6% 563,449 View
Mar 20, 2026 SCHEDULE 13G Raymond Debbane 5.1% 4,461,949 View
Mar 06, 2026 SCHEDULE 13G/A FMR LLC 12.5% 9,998,060 View
Mar 06, 2026 SCHEDULE 13G/A Abigail P. Johnson 12.5% 9,998,060 View
Feb 17, 2026 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 8.4% 6,710,194 View
Feb 17, 2026 SCHEDULE 13G/A Bain Capital Life Sciences Opportunities IV, L.P. 9.99% 8,508,641 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Capital, LP 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 0.0% 0 View
Feb 13, 2026 SCHEDULE 13G/A David Kroin 0.0% 0 View
Feb 05, 2026 SCHEDULE 13G FMR LLC 6.3% 5,023,092 View
Feb 05, 2026 SCHEDULE 13G Abigail P. Johnson 6.3% 5,023,092 View
Nov 14, 2025 SCHEDULE 13G JANUS HENDERSON GROUP PLC 5.2% 3,585,849 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.